Pfizer weighs sale of consumer unit

by | October 12, 2017 5:39 pm

Pfizer has said it is looking at a spin-off or sale of its consumer healthcare business in a move that could fetch up to $14bn for the US pharmaceuticals group and set off a flurry of dealmaking.   Pfizer said yesterday it was considering a range of options for the business, which makes Centrum vitamins…

This content is for Standard & Premium Digital Subscribers only.
Log In Subscribe